, Tracking Stock Market Picks
Enter Symbol:
Navidea Biopharmaceuticals Inc. (NAVB) [hlAlert]

Strong Buy
3 Months Gains
down 30.76 %

Neoprobe Corp. (NAVB) rated Strong Buy with price target $7 by WBB Securities

Posted on: Tuesday,  Sep 11, 2012  4:25 PM ET by WBB Securities

Neoprobe Corp. (AMEX: NAVB) rated
Strong Buy with price target $7 by WBB Securities.

Neoprobe Corporation (Neoprobe) is a biomedical company that develops and commercializes products that enhance patient care and improve patient outcome by meeting the intraoperative diagnostic information needs of physicians and therapeutic treatment needs of patients. The Company markets two lines of medical devices, which includes its neoprobe GDS gamma detection systems and the Quantix line of blood flow measurement devices of its subsidiary, Cardiosonix Ltd. In addition to its medical device products, it has two radiopharmaceutical products, Lymphoseek and RIGScan CR, in advanced phases of clinical development.

Research from WBB Securities provides investment professionals with up-to-date, in-depth, accurate and insightful reporting of companies that specialize in biotechnology, medical devices and healthcare. Our goal is to provide independent, straight-forward and up-to-date research so you can make educated decisions about your investments.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
9/11/2012 4:25 PM Buy
2.60 7.00
as of 1/1/0001
1 Week   
1 Month   
3 Months   
1 YTD   
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
5/5/2011 9:25 AM Buy
4.58 8.50
2/10/2011 8:25 AM Buy

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy